Related Experiment Video
Updated: Jun 14, 2026

Bacterial Artificial Chromosomes: A Functional Genomics Tool for the Study of Positive-strand RNA Viruses
Published on: December 29, 2015
Self-Amplifying RNA: Advantages and Challenges of a Versatile Platform for Vaccine Development
Thomas Vallet1,2, Marco Vignuzzi1,2
1A*STAR Infectious Diseases Labs (A*IDL), Agency for Science, Technology and Research (A*STAR), Singapore 138634, Singapore.
None:
Self-amplifying RNA is synthetic nucleic acid engineered to replicate within cells without generating viral particles. Derived from alphavirus genomes, saRNA retains the non-structural elements essential for replication while replacing the structural elements with an antigen of interest. By enabling efficient intracellular amplification, saRNA offers a promising alternative to conventional mRNA vaccines, enhancing antigen expression while requiring lower doses. However, this advantage comes with challenges. In this review, we highlight the key limitations of saRNA technology and explore potential strategies to overcome them. By identifying these challenges, we aim to provide insights that can guide the future design of saRNA-based therapeutics, extending their potential beyond vaccine applications.
More Related Videos
Related Concept Videos
Viral Mutations
Leaky Scanning
Microorganisms in Medicine and Therapeutics
Viruses with RNA Genomes
Vaccine Production
Vaccines

